Showing 841-850 of 3024 results for "".
Long-Term Neurologic Complications of COVID-19: A Practical Overview
https://practicalneurology.com/diseases-diagnoses/imaging-testing/long-term-neurologic-complications-of-covid-19-a-practical-overview/32150/The authors present an overview of the presentation and management of common neurologic symptoms associated with long COVID.- Turf Wars: Reports From the Front Linehttps://practicalneurology.com/columns/practice-management/turf-wars-reports-from-the-front-line/31111/In the October 2007 issue of Practical Neurology, Associate Editor Zac Haughn explores the complex landscape of professional conflicts and collaborations within the field of neurology. The article delves into the "turf wars" that arise when neurologists compete with other specialists, such as pulmon
Selection and Interpretation of Biomarker Tests for Alzheimer Disease
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/selection-and-interpretation-of-biomarker-tests-for-alzheimer-disease/36191/Diagnostic tests for Alzheimer disease can help guide clinical management, but results must be interpreted carefully.Hyperkinetic Movement Disorders
https://practicalneurology.com/diseases-diagnoses/movement-disorders/hyperkinetic-movement-disorders/30248/New treatments were approved in 2017 for tardive dyskinesia, Parkinson's dyskinesia, and Huntington's chorea.Advances in Neuromodulation for Essential Tremor
https://practicalneurology.com/diseases-diagnoses/movement-disorders/advances-in-neuromodulation-for-essential-tremor/32163/Advancements in neuromodulation continue to expand treatment options for medication-refractory essential tremor.Spinal Muscular Atrophy
https://practicalneurology.com/diseases-diagnoses/child-neurology/spinal-muscular-atrophy/31554/A devastating disease now has 2 approved breakthrough treatments available.2017 SMIC Update: What to Do Now
https://practicalneurology.com/columns/practice-management/2017-smic-update-what-to-do-now/30386/SMICs can be useful tools, but new requirements abound.Fringe Benefit Plans: Valuable Planning Tools You Haven't Heard Of
https://practicalneurology.com/columns/practice-management/tax-planning/30683/Fringe benefit plans lack many of the restrictions of qualified plans, and, therefore, are relatively inexpensive to implement.Utility of Autoantibody Profiles
https://practicalneurology.com/diseases-diagnoses/imaging-testing/utility-of-autoantibody-profiles/31704/Algorithmic testing for autoantibody profiles is more sensitive than physician-selected single autoantibody testing.Myasthenia Gravis Treatment
https://practicalneurology.com/diseases-diagnoses/neuromuscular/myasthenia-gravis-treatment-1/31690/There are both disease-modifying and symptom-reducing treatments available and emerging treatment possibilities.